These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 6363332

  • 1. [What is certain in the therapy of hepatocellular diseases with cyanidanol?].
    Schomerus H.
    Internist (Berl); 1983 Dec; 24(12):684-9. PubMed ID: 6363332
    [No Abstract] [Full Text] [Related]

  • 2. [Treatment of viral hepatitis and chronic hepatopathies with cianidanol].
    Chevrel B.
    Med Chir Dig; 1982 Dec; 11(1):77-80. PubMed ID: 7087577
    [No Abstract] [Full Text] [Related]

  • 3. [Effect of (+)-cyanidanol-3- on acute viral hepatitis. Preliminary results].
    Guadagnino V, De Mercato R, Piazza M.
    Clin Ter; 1977 Dec 15; 83(5):463-8. PubMed ID: 608309
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [A double-blind clinical study of the effect of a new molecule (+)-cyanidanol-3 on the course of the clinical symptoms and biological parameters of viral hepatitis].
    Cachin M, Dupuy R, Boutelier D, Levy C.
    Minerva Dietol Gastroenterol; 1977 Dec 15; 23(4):307-12. PubMed ID: 349422
    [No Abstract] [Full Text] [Related]

  • 9. [Influence of (+)-cyanidanol-3 on the course of acute viral hepatitis (author's transl)].
    Vido I, Schmidt FW, Müller R, Ranft U, Wildhirt E, Holzer E, Wallnöfer H, Korb G.
    Dtsch Med Wochenschr; 1980 Mar 07; 105(10):330-2. PubMed ID: 6153953
    [Abstract] [Full Text] [Related]

  • 10. The development of cianidanol and 3-palmitoyl-(+)-catechin as drugs for the treatment of liver diseases.
    Perrissoud D.
    Prog Clin Biol Res; 1986 Mar 07; 213():559-69. PubMed ID: 3520595
    [No Abstract] [Full Text] [Related]

  • 11. (+)-cyanidanol-3 in acute viral hepatitis.
    Blum AL.
    Lancet; 1978 Mar 04; 1(8062):501-2. PubMed ID: 76044
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Clinical study of the effect of the administration of cathergen preparation in patients with chronic hepatic lesions].
    Maleev A, Tsvetkova V, Krŭstev Z, Kostova N, Lukanov L.
    Vutr Boles; 1985 Mar 04; 24(5):39-43. PubMed ID: 4090451
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Effect of catergen on the course of acute viral hepatitis].
    Babiuch L, Poznańska H, Rychalska B.
    Przegl Epidemiol; 1981 Mar 04; 35(4):471-7. PubMed ID: 6803308
    [No Abstract] [Full Text] [Related]

  • 16. [Enzymologic evaluation of the effectiveness of the hepatotropic drug catergen in chronic liver diseases].
    Tamarkina AD, Neverov IV, Turitsyna IG, Dement'eva ES, Krylova NI.
    Sov Med; 1985 Mar 04; (12):26-30. PubMed ID: 4095626
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Treatment of chronic hepatitis. A comparative study of the effect azathioprine and (+)-cyanidanol-3].
    Aguilar Reina J, de la Santa López J, Cuadras Avellana CM, Kern A.
    Fortschr Med; 1978 Jan 12; 96(2):75-9. PubMed ID: 74352
    [Abstract] [Full Text] [Related]

  • 19. [A contribution as to the effect of (+)-Cyanidanol-3 in chronic liver disease (author's transl)].
    Sondern W, Leube G.
    Med Klin; 1978 Oct 13; 73(41):1432-6. PubMed ID: 703670
    [Abstract] [Full Text] [Related]

  • 20. Treatment of acute viral hepatitis with (+)-cyanidanol-3.
    Blum AL, Berthet P, Doelle W, Goebell H, Kortüm K, Pelloni S, Peter P, Poulsen H, Strohmeyer G, Tygstrup N.
    Lancet; 1977 Dec 03; 2(8049):1153-5. PubMed ID: 73062
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.